Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.060
+0.020 (0.66%)
At close: Sep 25, 2026, 4:00 PM EDT
3.070
+0.010 (0.32%)
After-hours: Sep 25, 2026, 7:51 PM EDT
Altimmune Revenue
Altimmune had revenue of $31.00K in the twelve months ending June 30, 2026, up 55.00% year-over-year. In the year 2025, Altimmune had annual revenue of $41.00K with 105.00% growth.
Revenue (ttm)
$31.00K
Revenue Growth
+55.00%
P/S Ratio
19,200.78
Revenue / Employee
$544
Employees
57
Market Cap
595.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 41.00K | 21.00K | 105.00% |
| Dec 31, 2024 | 20.00K | -406.00K | -95.31% |
| Dec 31, 2023 | 426.00K | 494.00K | - |
| Dec 31, 2022 | -68.00K | -4.48M | - |
| Dec 31, 2021 | 4.41M | -3.78M | -46.12% |
| Dec 31, 2020 | 8.19M | 2.38M | 41.09% |
| Dec 31, 2019 | 5.80M | -4.53M | -43.85% |
| Dec 31, 2018 | 10.33M | -407.15K | -3.79% |
| Dec 31, 2017 | 10.74M | 7.50M | 231.82% |
| Dec 31, 2016 | 3.24M | -7.40M | -69.59% |
| Dec 31, 2015 | 10.64M | 450.46K | 4.42% |
| Dec 31, 2014 | 10.19M | -7.72M | -43.11% |
| Dec 31, 2013 | 17.91M | -7.26M | -28.85% |
| Dec 31, 2012 | 25.18M | 909.61K | 3.75% |
| Dec 31, 2011 | 24.27M | 3.27M | 15.59% |
| Dec 31, 2010 | 20.99M | -6.56M | -23.80% |
| Dec 31, 2009 | 27.55M | -5.36M | -16.29% |
| Dec 31, 2008 | 32.91M | 18.27M | 124.75% |
| Dec 31, 2007 | 14.64M | 12.98M | 780.39% |
| Dec 31, 2006 | 1.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CorMedix | 462.25M |
| Phathom Pharmaceuticals | 239.66M |
| Valneva SE | 163.30M |
| CytomX Therapeutics | 18.30M |
| Crescent Biopharma | 11.88M |
| Allogene Therapeutics | 4.64M |
| Oculis Holding AG | 1.45M |
| Shattuck Labs | 1.00M |
ALT News
- 4 days ago - Altimmune price target lowered to $17 from $18 at Evercore ISI - TheFly
- 4 days ago - Altimmune to Participate in Stifel Cardiometabolic Forum - GlobeNewsWire
- 17 days ago - Altimmune Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 24 days ago - Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Altimmune reports Q2 EPS (12c), consensus (12c) - TheFly
- 6 weeks ago - Altimmune Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Altimmune Earnings release: Q2 2026 - Filings
- 6 weeks ago - Altimmune Quarterly report: Q2 2026 - Filings